High cortical bone mass phenotype in betacellulin transgenic mice is EGFR dependent

Journal of Bone and Mineral Research

Volumn 24, Issue 3, 2009, Pages 455-467

  Schneider, Marlon R ^a,b   Mayer Roenne, Bettina ^a,b   Dahlhoff, Maik ^a   Proell, Verena ^a   Weber, Karin ^a   Wolf, Eckhard ^a   Erben, Reinhold G ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF VETERINARY MEDICINE   (Austria)

Author keywords

Betacellulin; Bone mass; Epidermal growth factor receptor; Osteoblasts; Transgenic mice

Indexed keywords

BETACELLULIN; EPIDERMAL GROWTH FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; BONE DENSITY; BONE GROWTH; BONE MASS; CONTROLLED STUDY; CORTICAL BONE; FEMALE; FEMUR; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NEWBORN; NONHUMAN; OSTEOBLAST; OSTEOSCLEROSIS; OSTEOTOMY; PHENOTYPE; PROTEIN EXPRESSION; SEX; TRANSGENIC MOUSE; UPREGULATION; VERTEBRA; WESTERN BLOTTING;

AGING; ANIMALS; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; CHICKENS; FEMUR; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIGANDS; MICE; MICE, TRANSGENIC; ORGAN SIZE; OSTEOBLASTS; PHENOTYPE; RECEPTOR, EPIDERMAL GROWTH FACTOR; SPINE; TRANSGENES;

EID: 61849155838     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.081202     Document Type: Article

References (43)

1. Karsenty G, Wagner EF 2002 Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2:389-406.
2. Nakashima K, de Crombrugghe B 2003 Transcriptional mechanisms in osteoblast differentiation and bone formation. Trends Genet 19:458-466.
3. Yarden Y, Sliwkowski MX 2001 Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2:127-137.
4. Holbro T, Hynes NE 2004 ErbB receptors: Directing key signaling networks throughout life. Annu Rev Pharmacol Toxicol 44:195-217.
5. Citri A, Yarden Y 2006 EGF-ERBB signalling: Towards the systems level. Nat Rev Mol Cell Biol 7:505-516.
6. Harris RC, Chung E, Coffey RJ 2003 EGF receptor ligands. Exp Cell Res 284:2-13.
7. Martineau-Doize B, Lai WH, Warshawsky H, Bergeron JJ 1988 In vivo demonstration of cell types in bone that harbor epidermal growth factor receptors. Endocrinology 123:841-858.
8. Davideau JL, Sahlberg C, Thesleff I, Berdal A 1995 EGF receptor expression in mineralized tissues: An in situ hybridization and immunocytochemical investigation in rat and human mandibles. Connect Tissue Res 32:47-53.
9. Sibilia M, Wagner B, Hoebertz A, Elliott C, Marino S, Jochum W, Wagner EF 2003 Mice humanised for the EGF receptor display hypomorphic phenotypes in skin, bone and heart. Development 130:4515-4525.
10. Qin L, Tamasi J, Raggatt L, Li X, Feyen JH, Lee DC, Dicicco-Bloom E, Partridge NC 2005 Amphiregulin is a novel growth factor involved in normal bone development and in the cellular response to parathyroid hormone stimulation. J Biol Chem 280:3974-3981.
11. Ng KW, Partridge NC, Niall M, Martin TJ 1983 Stimulation of DNA synthesis by epidermal growth factor in osteoblast-like cells. Calcif Tissue Int 35:624-628.
12. Loza J, Carpio L, Lawless G, Marzec N, Dziak R 1995 Role of extracellular calcium influx in EGF-induced osteoblastic cell proliferation. Bone 16:341S-347S.
13. Kumegawa M, Hiramatsu M, Hatakeyama K, Yajima T, Kodama H, Osaki T, Kurisu K 1983 Effects of epidermal growth factor on osteoblastic cells in vitro. Calcif Tissue Int 35:542-548.
14. Hata R, Hori H, Nagai Y, Tanaka S, Kondo M, Hiramatsu M, Utsumi N, Kumegawa M 1984 Selective inhibition of type I collagen synthesis in osteoblastic cells by epidermal growth factor. Endocrinology 115:867-876.
15. Qin L, Qiu P, Wang L, Li X. Swarthout JT, Soteropoulos P, Tolias P, Partridge NC 2003 Gene expression profiles and transcription factors involved in parathyroid hormone signaling in osteoblasts revealed by microarray and bioinformatics. J Biol Chem 278:19723-19731.
16. Stern PH, Krieger NS, Nissenson RA, Williams RD, Winkler ME, Derynck R, Strewler GJ 1985 Human transforming growth factor-alpha stimulates bone resorption in vitro. J Clin Invest 76:2016-2019.
17. Marie PJ, Hott M, Perheentupa J 1990 Effects of epidermal growth factor on bone formation and resorption in vivo. Am J Physiol 258:E275-E281.
18. Raisz LG, Simmons HA, Sandberg AL, Canalis E 1980 Direct stimulation of bone resorption by epidermal growth factor. Endocrinology 107:270-273.
19. Chan SY, Wong RW 2000 Expression of epidermal growth factor in transgenic mice causes growth retardation. J Biol Chem 275:38693-38698.
20. Schneider MR, Dahlhoff M, Herbach N, Renner-Mueller I, Dalke C, Puk O, Graw J, Wanke R, Wolf E 2005 Betacellulin Overexpression in Transgenic Mice Causes Disproportionate Growth, Pulmonary Hemorrhage Syndrome, and Complex Eye Pathology. Endocrinology 146:5237-5246.
21. Lee D, Cross SH, Strunk KE, Morgan JE, Bailey CL, Jackson IJ, Threadgill DW 2004 Wa5 is a novel ENU-induced anti-morphic allele of the epidermal growth factor receptor. Mamm Genome 15:525-536.
22. Erben RG 1997 Embedding of bone samples in methyl-methacrylate: An improved method suitable for bone histo-morphometry, histochemistry, and immunohistochemistry. J Histochem Cytochem 45:307-313.
23. Schmidt J, Lumniczky K, Tzschaschel BD, Guenther HL, Luz A, Riemann S, Gimbel W, Erfle V, Erben RG 1999 Onset and dynamics of osteosclerosis in mice induced by Reilly-Finkel-Biskis (RFB) murine leukemia virus. Increase in bone mass precedes lymphomagenesis. Am J Pathol 155: 557-570.
24. Reim NS, Breig B, Stahr K, Eberle J, Hoeflich A, Wolf E, Erben RG 2008 Cortical bone loss in androgen-deficient aged male rats is mainly caused by increased endocortical bone remodeling. J Bone Miner Res 23:694-704.
25. Weber K, Kaschig C, Erben RG 2004 1 Alpha-hydroxyvitamin D2 and 1 alpha-hydroxyvitamin D3 have anabolic effects on cortical bone, but induce intracortical remodeling at toxic doses in ovariectomized rats. Bone 35:704-710.
26. Miyagawa J, Hanafusa O, Sasada R, Yamamoto K, Igarashi K, Yamamori K, Seno M, Tada H. Nammo T, Li M, Yamagata K, Nakajima H, Namba M, Kuwajima M, Matsuzawa Y 1999 Immunohistochemical localization of betacellulin, a new member of the EGF family, in normal human pancreas and islet tumor cells. Endocr J 46:755-764.
27. Pattyn F, Robbrecht P, De Paepe A, Speleman F, Vandesompele J 2006 RTPrimerDB: The real-time PCR primer and probe database, major update 2006. Nucleic Acids Res 34:D684-D688.
28. Pfaffl MW 2001 A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45.
29. Barnard JA, Graves-Deal R. Pittelkow MR, DuBois R, Cook P, Ramsey GW, Bishop PR, Damstrup L, Coffey RJ 1994 Auto-and cross-induction within the mammalian epidermal growth factor-related peptide family. J Biol Chem 269:22817-22822.
30. Vanky P, Brockstedt U, Hjerpe A, Wikstrom B 1998 Kinetic studies on epiphyseal growth cartilage in the normal mouse. Bone 22:331-339.
31. Wang K, Yamamoto H, Chin JR, Werb Z, Vu TH 2004 Epidermal growth factor receptor-deficient mice have delayed primary endochondral ossification because of defective osteoclast recruitment. J Biol Chem 279:53848-53856.
32. Schmidt C, Priemel M, Kohler T, Weusten A, Muller R, Amling M, Eckstein F 2003 Precision and accuracy of peripheral quantitative computed tomography (pQCT) in the mouse skeleton compared with histology and microcomputed tomography (microCT). J Bone Miner Res 18:1486-1496.
33. Brodt MD, Pelz GB, Taniguchi J, Silva MJ 2003 Accuracy of peripheral quantitative computed tomography (pQCT) for assessing area and density of mouse cortical bone. Calcif Tissue Int 73:411-418.
34. Edwards MW, Bain SD, Bailey MC, Lantry MM, Howard GA 1992 17 beta estradiol stimulation of endosteal bone formation in the ovariectomized mouse: An animal model for the evaluation of bone-targeted estrogens. Bone 13:29-34.
35. Ibbotson KJ, Orcutt CM, D'Souza SM, Paddock CL, Arthur JA, Jankowsky ML, Boyce RW 1992 Contrasting effects of parathyroid hormone and insulin-like growth factor I in an aged ovariectomized rat model of postmenopausal osteoporosis. J Bone Miner Res 7:425-432.
36. Lauritzen DB, Balena R, Shea M, Seedor JG, Markatos A, Le HM, Toolan BC, Myers ER, Rodan GA, Hayes WC 1993 Effects of combined prostaglandin and alendronate treatment on the histomorphometry and biomechanical properties of bone in ovariectomized rats. J Bone Miner Res 8:871-879.
37. Dobnig H, Turner RT 1995 Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. Endocrinology 136:3632-3638.
38. Zhou H, Iida-Klein A, Lu SS, Ducayen-Knowles M, Levine LR, Dempster DW, Lindsay R 2003 Anabolic action of parathyroid hormone on cortical and cancellous bone differs between axial and appendicular skeletal sites in mice. Bone 32:513-520.
39. Eriksen EF, Robins DA 2004 Teriparatide: A bone formation treatment for osteoporosis. Drugs Today (Bare) 40:935-948.
40. Fox J, Miller MA, Newman MK, Metcalfe AF, Turner CH, Recker RR, Smith SY 2006 Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength. Calcif Tissue Int 79:262-272.
41. Ma YL, Zeng Q, Donley DW, Ste-Marie LG, Gallagher JC, Dalsky GP, Marcus R, Eriksen EF 2006 Teriparatide increases bone formation in modeling and remodeling osteons and enhances IGF-II immunoreactivity in postmenopausal women with osteoporosis. J Bone Miner Res 21:855-864.
42. Manolagas SC 2000 Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21:115-137.
43. Martin TJ, Quinn JM, Gillespie MT, Ng KW, Karsdal MA, Sims NA 2006 Mechanisms involved in skeletal anabolic therapies. Ann NY Acad Sci 1068:458-470.